NIH-funded research R01 grant

Understanding how non-alcoholic fatty liver disease progresses to liver cancer

Official title: Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes

Funded at University of Pittsburgh at Pittsburgh · NIH-10907751 · Data updated 2026-11-12

This study is looking at what causes non-alcoholic fatty liver disease to get worse and possibly lead to liver cancer, so we can find better ways to prevent and treat it for people who are at risk.

More Carcinoma research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 7, 2021
Project endAugust 31, 2026
Funding year2024
Award (this year)$628,176
NIH project number5R01CA255809-04
Project IDNIH-10907751 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with non-alcoholic fatty liver disease, particularly those showing signs of progression towards more severe liver conditions.

Less likely to help

Patients without non-alcoholic fatty liver disease or those with other unrelated liver conditions may not benefit from this research.

What this research studies

This research investigates the factors that contribute to the progression of non-alcoholic fatty liver disease (NAFLD) into more severe conditions, including hepatocellular carcinoma, which is a type of liver cancer. The study aims to identify biological and environmental determinants that influence this progression, focusing on the liver's unique immune response and exposure to various substances. By analyzing patient data and liver samples, researchers hope to uncover new insights that could lead to effective prevention and treatment strategies for those at risk.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing liver cancer in patients with non-alcoholic fatty liver disease.

How similar studies have gone: Previous research has shown promising results in identifying risk factors for liver disease progression, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Yuan, Jian-Min — University of Pittsburgh at Pittsburgh
  • Study coordinator: Yuan, Jian-Min

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.